Blood Loss During Cesarean Delivery in Placenta Previa Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

May 4, 2022

Primary Completion Date

December 15, 2022

Study Completion Date

January 5, 2023

Conditions
Placenta Previa
Interventions
DRUG

Tranexamic acid

Patients will receive 1 gm tranexamic acid diluted in 20 ml of Glucose 5% 15 minutes prior to skin incision and a slow IV bolus of 5 IU oxytocin and 20 IU oxytocin in 500 mL lactated Ringer's solution (infused at a rate of 125 mL/h) following delivery of the baby.

DRUG

Misoprostol

"Patients will receive 400 microgram misoprostol which will be inserted inside the uterus near the cornu after delivery of the placenta and a slow IV bolus of 5 IU oxytocin and 20 IU oxytocin in 500 mL lactated Ringer's solution (infused at a rate of 125 mL/h).~."

DRUG

Oxytocin

Patients will receive an IV bolus of 5 IU oxytocin and 20 IU oxytocin in 500 mL lactated Ringer's solution (infused at a rate of 125 mL/h) following the delivery of the baby.

Trial Locations (1)

Unknown

Kasralainy Cairo University, Giza

All Listed Sponsors
lead

Cairo University

OTHER